Delayed-release budesonide (Tarpeyo) for primary immunoglobulin A nephropathy
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:64 |
|---|---|
| Enthalten in: |
The Medical letter on drugs and therapeutics - 64(2022), 1650 vom: 16. Mai, Seite 76-77 |
| Sprache: |
Englisch |
|---|
| Anmerkungen: |
Date Completed 12.05.2022 Date Revised 16.05.2022 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM340644443 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM340644443 | ||
| 003 | DE-627 | ||
| 005 | 20231226005846.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 028 | 5 | 2 | |a pubmed24n1135.xml |
| 035 | |a (DE-627)NLM340644443 | ||
| 035 | |a (NLM)35536122 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 245 | 1 | 0 | |a Delayed-release budesonide (Tarpeyo) for primary immunoglobulin A nephropathy |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.05.2022 | ||
| 500 | |a Date Revised 16.05.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ACE inhibitors | |
| 650 | 4 | |a ARBs | |
| 650 | 4 | |a Tarpeyo | |
| 650 | 4 | |a adverse effects | |
| 650 | 4 | |a budesonide | |
| 650 | 4 | |a corticosteroids | |
| 650 | 4 | |a dosage | |
| 650 | 4 | |a drug interactions | |
| 650 | 4 | |a efficacy | |
| 650 | 4 | |a lactation | |
| 650 | 4 | |a pregnancy | |
| 650 | 4 | |a safety | |
| 650 | 7 | |a Angiotensin Receptor Antagonists |2 NLM | |
| 650 | 7 | |a Angiotensin-Converting Enzyme Inhibitors |2 NLM | |
| 650 | 7 | |a Budesonide |2 NLM | |
| 650 | 7 | |a 51333-22-3 |2 NLM | |
| 773 | 0 | 8 | |i Enthalten in |t The Medical letter on drugs and therapeutics |d 1965 |g 64(2022), 1650 vom: 16. Mai, Seite 76-77 |w (DE-627)NLM000074810 |x 1523-2859 |7 nnns |
| 773 | 1 | 8 | |g volume:64 |g year:2022 |g number:1650 |g day:16 |g month:05 |g pages:76-77 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 64 |j 2022 |e 1650 |b 16 |c 05 |h 76-77 | ||